PROMOTE 720 GROWTH REGULATOR Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

promote 720 growth regulator

adama australia pty limited - ethephon - aqueous concentrate - ethephon organophosphorus active 720.0 g/l - growth regulator - apple - legana | apple - stark crimson | barley | barley - malebo variety | barley - parwan variety | barley - weeah variety | c - accelerate ripening | acceleration of boll opening | advance/concentrate fruit maturity | aid complete removal of fruit from trees | aid mechanical harvesting | anti lodging | defoliation of cotton plants | early colour development | encourage biennial bearing habit | even out production cycle | fruit thinning | increase fruit maturity or colour | increase fruit yield | initiate flowering in ratoon | initiating flowering | loosen fruit | pre-conditioning treatment | promote eveness of maturity | promote uniform nutfall | reduce size of heavy crop | reduce vegetative growth | stimulate flowering in following season | control excess vine growth | control excess.veg.growth | defoliation aid | fruit thinning | increased red colour | increasing fruit yield | promotes flowering | reduce fire hazard/ weed growt | stimulate following bloom | suppress vegetative growth

FLUTIK POUR-ON TICK DEVELOPMENT INHIBITOR Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

flutik pour-on tick development inhibitor

elanco australasia pty ltd - fluazuron; 1-octyl-2-pyrrolidinone; 1-dodecyl-2-pyrrolidinone; 1-methyl-2-pyrrolidinone - topical solution/suspension - fluazuron ungrouped active 25.0 g/l; 1-octyl-2-pyrrolidinone ungrouped other 100.0 g/l; 1-dodecyl-2-pyrrolidinone ungrouped other 100.0 g/l; 1-methyl-2-pyrrolidinone solvent other 415.0 g/l - parasiticides - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - cattle tick

ECHEM ETHEPHON GROWTH REGULATOR Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

echem ethephon growth regulator

echem (aust) pty limited - ethephon - aqueous concentrate - ethephon organophosphorus active 720.0 g/l - growth regulator - apple | apple - legana | apple - stark crimson | cherry - florence | cherry - napoleon | cherry - ron's seedling | cherry - st m - accelerate ripening | acceleration of boll opening | advance/concentrate fruit maturity | aid complete removal of fruit from trees | aid mechanical harvesting | defoliation of cotton plants | early colour development | encourage biennial bearing habit | even out production cycle | fruit thinning | increase fruit maturity or colour | increase fruit yield | initiate flowering in ratoon | initiating flowering | loosen fruit | pre-conditioning treatment | promote eveness of maturity | promote uniform nutfall | reduce size of heavy crop | reduce vegetative growth | stimulate flowering in following season | control excess vine growth | control excess.veg.growth | defoliation aid | fruit thinning | increased red colour | increasing fruit yield | promotes flowering | reduce fire hazard/ weed growt | stimulate following bloom | suppress vegetative growth

PROGIBB SG PLANT GROWTH REGULATOR SOLUBLE GRANULE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

progibb sg plant growth regulator soluble granule

valent biosciences a div of sumitomo chemical australia - gibberellic acid - water soluble granules - gibberellic acid plant growth regulator active 400.0 g/kg - growth regulator - cherry | grape - currant (dried fruit) | grape - early madeleine | grape - flame seedless | grape - perlette | grape - sultana | - improve berry set | improve fruit development | improve fruit quality | increase bunch size | promote desirable harvest effects | reduction in severity of creasing | stimulate production | growth stimulation | rapid plant growth | to achieve berry thinning | to achieve bunch elongation (s | to achieve increase in berry s | to delay rind ageing | to improve storage life | to reduce rind blemish

LAURABOLIN 25 MG/ML ANABOLIC STEROID FOR INTRAMUSCULAR OR SUBCUTANEOUS INJECTION Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

laurabolin 25 mg/ml anabolic steroid for intramuscular or subcutaneous injection

intervet australia pty limited - nandrolone laurate - parenteral liquid/solution/suspension - nandrolone laurate steroid-anabolic active 25.0 mg/ml - endocrine system - cat | dog | horse | horse foal | bitch | castrate | cat - queen | cat - tom | colt | donkey | endurance horse | filly | foal | g - anabolic steroid | abortion threat | androgenic properties | bone repair | catabolic complications | convalescence | erythropoietic activity | geriatric therapy | improve appetite | male sexual characterisitics | muscle development | non-virilising anabolic | pathophysiological process | protein and mineral anabolic | skeletal conditions | tissue breakdown | tissue repair | virilising anabolic

ROOTEX-L HORMONE ROOTING LIQUID Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rootex-l hormone rooting liquid

bass laboratories pty ltd - indole butyric acid = iba - liquid concentrate - indole butyric acid = iba plant growth regulator active 4.0 g/l - plant regulator - cutting - acceleration of root development growth | rooting induction | induction of rooting | root stimulation | root striking

TRAJENTA  DUO  2.5 MG 500 MG Israel - English - Ministry of Health

trajenta duo 2.5 mg 500 mg

boehringer ingelheim israel ltd. - linagliptin; metformin hydrochloride - film coated tablets - metformin hydrochloride 500 mg; linagliptin 2.5 mg - metformin - metformin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate. trajenta-duo should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. trajenta-duo has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using trajenta-duo.

TRAJENTA DUO  2.5 MG  850 MG Israel - English - Ministry of Health

trajenta duo 2.5 mg 850 mg

boehringer ingelheim israel ltd. - linagliptin; metformin hydrochloride - film coated tablets - metformin hydrochloride 850 mg; linagliptin 2.5 mg - metformin - metformin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate. trajenta-duo should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. trajenta-duo has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using trajenta-duo.

TRAJENTA DUO 2.5 MG 1000 MG Israel - English - Ministry of Health

trajenta duo 2.5 mg 1000 mg

boehringer ingelheim israel ltd. - linagliptin; metformin hydrochloride - film coated tablets - linagliptin 2.5 mg; metformin hydrochloride 1000 mg - metformin - metformin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate. trajenta-duo should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. trajenta-duo has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using trajenta-duo.

TRAJENTA Israel - English - Ministry of Health

trajenta

boehringer ingelheim israel ltd. - linagliptin - film coated tablets - linagliptin 5 mg - linagliptin - linagliptin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. trajenta should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. trajenta has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using trajenta.